MYCOF - Mydecine Innovations Group GAAP EPS of -$0.41 May, 16 2023 04:40 PM New Age Brands 2023-05-16 16:40:50 ET Mydecine Innovations Group press release ( OTCPK:MYCOF ): Q1 GAAP EPS of -$0.41. The Company had $10,291 in cash and cash equivalents as of March 31, 2023. For further details see: Mydecine Innovations Group GAAP EPS of -$0.41